A blog about what is new (and old) in the world of active implantable medical devices 

Facebook Twitter Gplus Flickr LinkedIn YouTube RSS
magnify
formats

Medtronic Receives FDA Appoval for Expanded Use of CRT-D to Class II HF

Medtronic received FDA approval for the expanded use of CRT-D in mildly-symptomatic heart failure patients.  The expanded indication includes New York Heart Association (NYHA) Class II heart failure patients with a left ventricular ejection fraction (LVEF) of less than or equal to 30 percent, left bundle branch block (LBBB), and a QRS duration greater than

 
 Share on Facebook Share on Twitter Share on Reddit Share on LinkedIn
Comments Off on Medtronic Receives FDA Appoval for Expanded Use of CRT-D to Class II HF  comments